Ariad Pharmaceuticals, Inc. (ARIA) Moving Average Crossover Spotted - Tale of the Tape
Ariad Pharmaceuticals, Inc. (
could be a stock to avoid from a technical perspective, as the
firm is seeing unfavorable trends on the moving average crossover
front. Recently, the 50 Day Moving Average for
broke out below the 200 Day Simple Moving Average, suggesting
This has already started to take place, as the stock has moved lower by 23.89% in the past four weeks. Plus, the company currently has a Zacks Rank #4 (Sell) meaning that now could definitely be the time to get out of this potentially in-trouble stock.
ARIAD PHARMA (ARIA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research